Video

Treat-to-Target in Rheumatoid Arthritis

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Related Videos
Woman experiencing pain related to recurrent pericarditis -- Image credit: Art_Photo | stock.adobe.com
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
Related Content
Blood plasma as a hope for treatment of coronavirus infection. Syringe with blood plasma in a hand in a blue medical glove against the sky. Platelet-Rich plasma preparation.
February 21st 2025

Administering Plasma Therapy Requires Pharmacist Collaboration With Specialty Care Team

Luke Halpern, Assistant Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

ACTIVATE-Kids Study Demonstrates Efficacy of Oral Therapy for Children With PK Deficiency
February 20th 2025

ACTIVATE-Kids Study Demonstrates Efficacy of Oral Therapy for Children With PK Deficiency

Aislinn Antrim, Managing Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Pharmaceutical Market Research, drug development, clinical trials, market size, competitive analysis, regulatory compliance, FDA approval, 4K, HD - Image credit: Aryan | stock.adobe.com
February 18th 2025

Condition Watch: Biosimilars

Ashley Gallagher, Editor
Amgen Prolia Denosumab for injection in pre-filled syringe with protective cap. Monoclonal antibody used to treat bone loss in women post menopause
February 17th 2025

FDA Approves Biosimilar Denosumab-dssb to Treat Osteoporosis-, Cancer-Related Bone Loss

Luke Halpern, Assistant Editor